Chan Lee joined BeiGene as General Counsel in July 2022.
Mr. Lee previously worked at Sanofi from 2016 to 2022, where he served as North America General Counsel and Head of Legal for the Specialty Care Global Business Unit, responsible for the legal oversight of the company’s U.S. and Canada businesses and its global Specialty Care business. Prior to Sanofi, he held roles of increasing responsibility from 2008 to 2016 at Pfizer, most notably as Chief Counsel for Pfizer’s Innovative Health global business, and, earlier, as Chief Counsel for the Vaccines, Oncology and Consumer Health global businesses, and as Assistant General Counsel for Asia.
Mr. Lee earned his J.D. from the University of California at Berkeley and his B.S. in applied economics from Cornell University.